Stroke News

Healio | Cardiology Today compiled a list of the top headlines in cardiology of January 2024.

Adults who achieve type 2 diabetes remission are less likely to develop chronic kidney disease and cardiovascular disease, according to study findings published in Diabetologia.

A novel smartphone app was shown to diagnose vestibular stroke symptoms via tracked eye movements in healthy volunteers with an accuracy similar to current clinical standard devices, researchers reported.

In a phase 2 trial, reteplase was well tolerated with a similar efficacy and safety profile to that of alteplase as an alternative IV thrombolytic treatment for acute ischemic stroke, researchers reported.

Compared with unvaccinated individuals, the recombinant zoster vaccine reduces the 3-year risk for mortality and myocardial infarction among individuals aged 50 to 65 years, according to a study.

SAN DIEGO — Guideline-directed use of hydroxyurea may reduce cerebrovascular disease among individuals with sickle cell disease, according to single-center study results.

Direct oral anticoagulants have become the standard of care for stroke prevention in patients with atrial fibrillation, among other indications, but factor XI/XIa inhibitors may have the potential to usurp them due to safety profiles.

In adults with atrial fibrillation who developed ischemic stroke, those treated with left atrial appendage closure had better outcomes than those receiving direct oral anticoagulant prophylaxis, data from a registry analysis show.

Medtronic announced the U.S. launch of its left atrial appendage exclusion system for use during cardiac surgery in patients with preoperative atrial fibrillation.

Patients with obstructive sleep apnea who have heart failure, are of older age or use an oronasal CPAP mask faced an increased risk for high residual apnea-hypopnea index variability, according to results published in CHEST.